Literature DB >> 52050

Treatment of deep-vein thrombosis with intermittent streptokinase and plasminogen infusion.

V V Kakkar, S Sagar, M Lewis.   

Abstract

17 consecutive patients who presented with extensive deep-vein thrombosis, confirmed by phlebography, were included in this study. Of 12 patients who received streptokinase and plasminogen infusion, complete lysis of thrombi was obtained in 8 and partial but extensive lysis in 4. In contrast, thrombi remained unchanged in each of 5 patients who received the same doses of streptokinase infusion only.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52050     DOI: 10.1016/s0140-6736(75)90774-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

Review 1.  Guidelines for treatment and prevention of venous thromboembolism among patients with cancer.

Authors:  Nicole M Kuderer; Gary H Lyman
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

2.  Streptokinase.

Authors: 
Journal:  Br Med J       Date:  1977-04-09

3.  Twelve years experience of vena cava filtration.

Authors:  N R Lagattolla; K G Burnand; A Irvine; D Ferrar
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

4.  Subacute massive pulmonary embolism treated with plasminogen and streptokinase.

Authors:  D A Ellis; E Neville; R J Hall
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.